首页> 外文期刊>BMC Complementary and Alternative Medicine >Suppression of low-density lipoprotein oxidation, vascular smooth muscle cell proliferation and migration by a herbal extract of Radix Astragali, Radix Codonopsis and Cortex Lycii
【24h】

Suppression of low-density lipoprotein oxidation, vascular smooth muscle cell proliferation and migration by a herbal extract of Radix Astragali, Radix Codonopsis and Cortex Lycii

机译:黄芪,党参,枸杞中药提取物对低密度脂蛋白氧化,血管平滑肌细胞增殖和迁移的抑制作用

获取原文
           

摘要

Background Atherosclerosis is a major cause of death in developed world. Atherosclerosis is characterized by low-density lipoprotein deposition in the arterial wall which ultimately begets the formation of lesions. Rupture of lesions finally leads to clinical events such as heart attack and stroke. Atherosclerosis is a complication associated with diabetes. In patients with diabetes, the risk of atherosclerosis is three to five folds greater than in non-diabetics. Our previous study showed that a herbal extract of Radix Astragali, Radix Codonopsis and Cortex Lycii, namely SR10, could improve glucose homeostasis both in vitro and in vivo. In this study, we want to further investigate the efficacy of SR10 in treating atherosclerosis. Method The inhibitory effect of SR10 on low-density lipoprotein oxidation was investigated using free radical-induced erythrocyte hemolysis model and copper ion-induced low-density lipoprotein oxidation model. Since vascular smooth muscle cell proliferation and migration are important processes in atherogenesis, we also examined the effect of SR10 in inhibiting these events. Results Our results showed that SR10 inhibited erythrocyte hemolysis with IC50 value at 0.25 mg/ml and significantly prolonged low-density lipoprotein oxidation in vitro. SR10 attenuated platelet derived growth factor-BB-induced vascular smooth muscle cell proliferation by promoting cell cycle arrest at G0/G1 phase as well as inhibiting vascular smooth muscle cell migration. Conclusion The potential application of SR10 in treating atherosclerosis has been implied in this study. Animal model will be needed to further verify the efficacy of SR10 in future.
机译:背景技术动脉粥样硬化是发达国家的主要死亡原因。动脉粥样硬化的特征是低密度脂蛋白沉积在动脉壁中,最终导致病变的形成。损伤的破裂最终导致临床事件,例如心脏病发作和中风。动脉粥样硬化是与糖尿病有关的并发症。在糖尿病患者中,动脉粥样硬化的风险是非糖尿病患者的三到五倍。我们以前的研究表明,黄芪,党参和枸杞的草药提取物SR10可以改善体内和体外的葡萄糖稳态。在这项研究中,我们想进一步研究SR10在治疗动脉粥样硬化中的功效。方法采用自由基诱导的红细胞溶血模型和铜离子诱导的低密度脂蛋白氧化模型,研究SR10对低密度脂蛋白氧化的抑制作用。由于血管平滑肌细胞的增殖和迁移是动脉粥样硬化的重要过程,因此我们还研究了SR10在抑制这些事件中的作用。结果我们的结果表明SR10抑制红细胞溶血,其IC 50 值为0.25 mg / ml,并显着延长了体外低密度脂蛋白的氧化。 SR10通过促进G 0 / G 1 期的细胞周期阻滞以及抑制血管平滑肌细胞迁移来减弱血小板衍生的生长因子-BB诱导的血管平滑肌细胞增殖。结论本研究暗示了SR10在动脉粥样硬化中的潜在应用。将来需要动物模型来进一步验证SR10的功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号